These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3). Martin WR; Fraser HF; Gorodetzky CW; Rosenberg DE J Pharmacol Exp Ther; 1965 Dec; 150(3):426-36. PubMed ID: 5322320 [No Abstract] [Full Text] [Related]
24. Central neurohumoral systems involved with narcotic agonists and antagonists. Harris LS Fed Proc; 1970; 29(1):28-31. PubMed ID: 4391649 [No Abstract] [Full Text] [Related]
25. Counteraction of narcotic antagonist analgesics by the narcotic antagonist Naloxone. Blumberg H; Dayton HB; Wolf PS Proc Soc Exp Biol Med; 1966 Dec; 123(3):755-8. PubMed ID: 4381176 [No Abstract] [Full Text] [Related]
26. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists. Fraser HF Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198 [No Abstract] [Full Text] [Related]
27. Methodology for the evaluation of pentazocine, prototype of the new morphine agonist-antagonist analgesics. Seevers MH Int J Clin Pharmacol; 1974 Apr; 7(3):167-73. PubMed ID: 4212164 [No Abstract] [Full Text] [Related]
28. Assays for narcotic antagonist activity in rodents. Pierson AK Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786 [No Abstract] [Full Text] [Related]
29. Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine). Martin WR; Gorodetzky CW J Pharmacol Exp Ther; 1965 Dec; 150(3):437-42. PubMed ID: 5322321 [No Abstract] [Full Text] [Related]
30. Agonistic properties of narcotic analgesics and antagonists on the electroencephalogram and behavior in the rat and their reversal by naloxone. Colasanti B; Khazan N Neuropharmacology; 1973 Jul; 12(7):619-27. PubMed ID: 4730371 [No Abstract] [Full Text] [Related]
31. [Use of narcotic antagonists after analgesic anesthesia]. De Castro J; Parmentier P; Andrieu S Ann Anesthesiol Fr; 1976; 17(10):1103-13. PubMed ID: 14562 [No Abstract] [Full Text] [Related]
32. Potent long-acting antagonists of the 9,9-dialkylbenzomorphan series. Janssen PA Adv Biochem Psychopharmacol; 1973; 8(0):109-11. PubMed ID: 4795015 [No Abstract] [Full Text] [Related]
33. Analgesic and dependence studies with oripavine partial agonists. Cowan A; Lewis JW; Macfarlane IR; Whittle BA Br J Pharmacol; 1971 Oct; 43(2):461P-462P. PubMed ID: 5168272 [No Abstract] [Full Text] [Related]
35. The pharmacology of (minus)-3-hydroxy-N-cyclopropylmethylmorphinan (cyclorphan). Harris LS; Pierson AK; Dembinski JR; Dewey WL Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):112-26. PubMed ID: 4382141 [No Abstract] [Full Text] [Related]
36. Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum. Gyand EA; Kosterlitz HW Br J Pharmacol Chemother; 1966 Sep; 27(3):514-27. PubMed ID: 5970903 [No Abstract] [Full Text] [Related]
37. Effects of analgesics and other drugs on mice in phenylquinone and rotarod tests. Pearl J; Stander H; McKean DB J Pharmacol Exp Ther; 1969 May; 167(1):9-13. PubMed ID: 5772754 [No Abstract] [Full Text] [Related]
38. Brain acetylcholine levels and inhibition of the tail-flick reflex in mice. Howes JF; Harris LS; Dewey WL; Voyda CA J Pharmacol Exp Ther; 1969 Sep; 169(1):23-8. PubMed ID: 5804609 [No Abstract] [Full Text] [Related]